High throughput screening system for development of anti-cancer drugs inducing HER2 internalization

被引：0
|
作者：
Isa, Masayuki [1 ]
Asanuma, Daisuke [1 ]
Namiki, Shigeyuki [1 ]
Kumagai, Kazuo [2 ]
Kojima, Hirotatsu [2 ]
Okabe, Tajayoshi [2 ]
Nagano, Tetsuo [2 ]
Hirose, Kenzo [1 ]
机构：
[1] Univ Tokyo, Sch Med, Dept Neurobiol, Bunkyo Ku, Tokyo 1130033, Japan
[2] Univ Tokyo, Sch Med, OCDD, Bunkyo Ku, Tokyo 1130033, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2013年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：232P / 232P
页数：1
相关论文
共 50 条
  • [21] Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells
    Kim, Jinkyoung
    Lee, Jiyun
    Kim, Chungyeul
    Choi, Jinhyuk
    Kim, Aeree
    TUMOR BIOLOGY, 2016, 37 (05) : 5811 - 5819
  • [22] Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody
    Cheng, Jackie
    Liang, Meina
    Carvalho, Miguel F.
    Tigue, Natalie
    Faggioni, Raffaella
    Roskos, Lorin K.
    Vainshtein, Inna
    ANTIBODIES, 2020, 9 (03) : 1 - 21
  • [23] THE DEVELOPMENT, OPTIMIZATION AND VALIDATION OF A HIGH THROUGHPUT SCREENING ASSAY FOR ANTI-MALARIA DRUGS DISCOVERY
    Che, Pulin
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 81 (05): : 47 - 48
  • [24] High-throughput anti-cancer compound screening for automated assessments of WIPI-dependent autophagy
    Zuleger, T.
    Mueller, A. J.
    Mauthe, M.
    Proikas-Cezanne, T.
    FEBS JOURNAL, 2015, 282 : 375 - 375
  • [25] HER2 missense mutations in breast cancer cells do not alter HER2 internalization or sensitivity to T-DM1
    Akamatsu, Hiroaki
    Mino, Rosa
    Mettlen, Marcel
    Ye, Dan
    Sudhan, Dhivya R.
    Lin, Albert
    Marin, Arnaldo
    Servetto, Alberto
    Lee, Kyung-min
    Chatterjee, Sumanta
    Schmid, Sandra L.
    Arteaga, Carlos L.
    Hanker, Ariella B.
    CANCER RESEARCH, 2020, 80 (16)
  • [26] DEVELOPMENT OF ANTI-P185(HER2) IMMUNOLIPOSOMES FOR CANCER-THERAPY
    PARK, JW
    HONG, K
    CARTER, P
    ASGARI, H
    GUO, LY
    KELLER, GA
    WIRTH, C
    SHALABY, R
    KOTTS, C
    WOOD, WI
    PAPAHADJOPOULOS, D
    BENZ, CC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) : 1327 - 1331
  • [27] The development of an automated high throughput screening system
    Harding, D
    PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON LABORATORY AUTOMATION AND ROBOTICS 1996, 1997, : 296 - 308
  • [28] Synthesis and biological evaluation of anti-cancer agents that selectively inhibit Her2 over-expressed breast cancer cell growth via down-regulation of Her2 protein
    Zhao, Anran
    Zheng, Qiaoyun
    Orahoske, Cody M.
    Idippily, Nethrie D.
    Ashcraft, Morgan M.
    Quamine, Aicha
    Su, Bin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (04) : 727 - 731
  • [29] Advances in Small-Molecule Dual Inhibitors Targeting EGFR and HER2 Receptors as Anti-Cancer Agents
    Kang, Jia-Xiong
    Li, Chao
    Cheng, Yi-Mei
    Huang, Mou-Xin
    Zhao, Guang-Kuan
    Jin, Zhi-Liang
    Qi, Xiao-Wei
    Gu, Jing
    Ouyang, Qin
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [30] The perspective of anti-HER2 therapy for HER2 positive breast cancer
    Iwata, Hiroji
    ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
12345